The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review
Open accessAbstract
PURPOSE: A systematic literature review was done to determine the relationship between elevated CRP and prognosis in people with solid tumors. C-reactive protein (CRP) is a serum acute phase reactant and a well-established inflammatory marker. We also examined the role of CRP to predict treatment response and tumor recurrence. METHODS: MeSH (Medical Subject Heading) terms were used to search multiple electronic databases (PubMed, EMBASE, Web of Science, SCOPUS, EBM-Cochrane). Two independent reviewers selected research papers. We also included a quality Assessment (QA) score. Reports with QA scores <50% were excluded. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) methodology was utilized for this review (S1 PRISMA Checklist). RESULTS: 271 articles were identified for final review. There were 45% prospective studies and 52% retrospective. 264 had intermediate QA score (≥50% but <80%); Seven were adequate (80% -100%); A high CRP was predictive of prognosis in 90% (245/271) of studies-80% of the 245 studies by multivariate analysis, 20% by univariate analysis. Many (52%) of the articles were about gastrointestinal malignancies (GI) or kidney malignancies. A high CRP was prognostic in 90% (127 of 141) of the reports in those groups of tumors. CRP was also prognostic in most reports in other solid tumors primary sites. CONCLUSIONS: A high CRP was associated with higher mortality in 90% of reports in people with solid tumors primary sites. This was particularly notable in GI malignancies and kidney malignancies. In other solid tumors (lung, pancreas, hepatocellular cancer, and bladder) an elevated CRP also predicted prognosis. In addition there is also evidence to support the use of CRP to help decide treatment response and identify tumor recurrence. Better designed large scale studies should be conducted to examine these issues more comprehensively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.02.007 · Cited by 12,156
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162
An Introduction to Medical Statistics.
(1931) · Journal of the American Medical Association · doi:10.1001/jama.1931.02730150055037 · Cited by 2,084
Black, S., Kushner, I., & Samols, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400025200 · Cited by 1,844
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Fearon, K. C., Voss, A. C., & Hustead, D. S. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1345 · Cited by 779
Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers
Hayes, D. F., Bast, R. C., Desch, C. E., Fritsche, H., Kemeny, N. E., Jessup, J. M., Locker, G. Y., Macdonald, J. S., Mennel, R. G., Norton, L., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1456 · Cited by 748
REporting recommendations for tumor MARKer prognostic studies (REMARK)
for the Statistics Subcommittee of the NCI—EORTC Working Group on Cancer Diagnostics (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0252 · Cited by 561
McMillan, D. C., Crozier, J. E. M., Canna, K., Angerson, W. J., & McArdle, C. S. (2007) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0259-6 · Cited by 533
Proctor, M. J., Morrison, D. S., Talwar, D., Balmer, S. M., O'Reilly, D. S. J., Foulis, A. K., Horgan, P. G., & McMillan, D. C. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606087 · Cited by 531
Cleeland, C. S., Bennett, G. J., Dantzer, R., Dougherty, P. M., Dunn, A. J., Meyers, C. A., Miller, A. H., Payne, R., Reuben, J. M., Wang, X. S., et al. (2003) · Cancer · doi:10.1002/cncr.11382 · Cited by 526
Systemic inflammatory response predicts survival following curative resection of colorectal cancer
McMillan, D. C., Canna, K., & McArdle, C. S. (2003) · British Journal of Surgery · doi:10.1002/bjs.4038 · Cited by 454
Koenig, W., Löwel, H., Baumert, J., & Meisinger, C. (2004) · Circulation · doi:10.1161/01.cir.0000120707.98922.e3 · Cited by 445
Heikkilä, K., Ebrahim, S., & Lawlor, D. A. (2007) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2006.051292 · Cited by 429
SERUM C‐REACTIVE PROTEIN LEVELS IN DISEASE*
Morley, J. J., & Kushner, I. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22153.x · Cited by 421
Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma.
Blay, J., Négrier, S., Combaret, V., Attali, S., Goillot, E., Merrouche, Y., Mercatello, A., Ravault, A., Tourani, J. M., & Jf, M. (1992) · PubMed · Cited by 420
Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer
Allin, K. H., Bojesen, S. E., & Nordestgaard, B. G. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8440 · Cited by 419
What Does Minor Elevation of C-Reactive Protein Signify?
Kushner, I., Rzewnicki, D., & Samols, D. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.057 · Cited by 372
Evaluation of an inflammation‐based prognostic score in patients with metastatic renal cancer
Ramsey, S., Lamb, G. W. A., Aitchison, M., Graham, J., & McMillan, D. C. (2007) · Cancer · doi:10.1002/cncr.22400 · Cited by 334
The role of C-reactive protein as a prognostic indicator in advanced cancer
Mahmoud, F. A., & Rivera, N. I. (2002) · Current Oncology Reports · doi:10.1007/s11912-002-0023-1 · Cited by 325
Leitch, E. F., Chakrabarti, M., Crozier, J. E. M., McKee, R. F., Anderson, J. H., Horgan, P. G., & McMillan, D. C. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604027 · Cited by 307
Ishizuka, M., Nagata, H., Takagi, K., Horie, T., & Kubota, K. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e3181454171 · Cited by 272
Palliative Medicine Review: Prognostication
Glare, P. A., & Sinclair, C. T. (2008) · Journal of Palliative Medicine · doi:10.1089/jpm.2008.9992 · Cited by 252
Metastatic renal carcinoma comprehensive prognostic system
and DGCIN - German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group, Atzpodien, J., Royston, P., Wandert, T., & Reitz, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600768 · Cited by 241
Gondo, T., Nakashima, J., Ohno, Y., Choichiro, O., Horiguchi, Y., Namiki, K., Yoshioka, K., Ohori, M., Hatano, T., & Tachibana, M. (2012) · Urology · doi:10.1016/j.urology.2011.11.070 · Cited by 229
Canna, K., McArdle, P. A., McMillan, D. C., McNicol, A.-M., Smith, G. W., McKee, R. F., & McArdle, C. S. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602419 · Cited by 226
Wang, D.-S., Luo, H.-Y., Qiu, M.-Z., Wang, Z.-Q., Zhang, D.-S., Wang, F.-H., Li, Y.-H., & Xu, R.-H. (2012) · Medical Oncology · doi:10.1007/s12032-012-0226-8 · Cited by 224
Nozoe, T., Matsumata, T., Kitamura, M., & Sugimachi, K. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00204-9 · Cited by 223
Ohno, Y., Nakashima, J., Ohori, M., Hatano, T., & Tachibana, M. (2010) · Journal of Urology · doi:10.1016/j.juro.2010.05.028 · Cited by 217
Malik, H. Z., Prasad, K. R., Halazun, K. J., Aldoori, A., Al-Mukhtar, A., Gomez, D., Lodge, J. P. A., & Toogood, G. J. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318142d964 · Cited by 204
Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer
Hefler, L. A., Concin, N., Hofstetter, G., Marth, C., Mustea, A., Sehouli, J., Zeillinger, R., Leipold, H., Lass, H., Grimm, C., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1044 · Cited by 199
An Introduction to Medical Statistics
&NA; (1990) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-199002000-00038 · Cited by 183
Read, J. A., Boris Choy, S. T., Beale, P. J., & Clarke, S. J. (2006) · Nutrition and Cancer · doi:10.1207/s15327914nc5501_10 · Cited by 182
Inoue, A., Kunitoh, H., Sekine, I., Sumi, M., Tokuuye, K., & Saijo, N. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00783-5 · Cited by 182
Pinato, D. J., Stebbing, J., Ishizuka, M., Khan, S. A., Wasan, H. S., North, B. V., Kubota, K., & Sharma, R. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.022 · Cited by 181
Kim, D.-K., Oh, S. Y., Kwon, H.-C., Lee, S., Kwon, K. A., Kim, B. G., Kim, S.-G., Kim, S.-H., Jang, J. S., Kim, M. C., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-155 · Cited by 181
Karakiewicz, P. I., Hutterer, G. C., Trinh, Q., Jeldres, C., Perrotte, P., Gallina, A., Tostain, J., & Patard, J. (2007) · Cancer · doi:10.1002/cncr.22896 · Cited by 163
Crumley, A. B. C., McMillan, D. C., McKernan, M., Going, J. J., Shearer, C. J., & Stuart, R. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603150 · Cited by 161
Riley, R. D., Sauerbrei, W., & Altman, D. G. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604999 · Cited by 161
Serum IL-6, TNFα and CRP levels in Greek colorectal cancer patients: Prognostic implications
Nikiteas, N. I. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i11.1639 · Cited by 156
McMillan, D. C., Wotherspoon, H., Fearon, K. C. H., Sturgeon, C., Cooke, T. G., & McArdle, C. S. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80296-7 · Cited by 153
Jiang, X., Hiki, N., Nunobe, S., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.262 · Cited by 152
Allin, K. H., Nordestgaard, B. G., Flyger, H. L., & Bojesen, S. E. (2011) · Breast Cancer Research · doi:10.1186/bcr2891 · Cited by 152
Preoperative C‐reactive protein as a prognostic and therapeutic marker for colorectal cancer
Koike, Y., Miki, C., Okugawa, Y., Yokoe, T., Toiyama, Y., Tanaka, K., Inoue, Y., & Kusunoki, M. (2008) · Journal of Surgical Oncology · doi:10.1002/jso.21154 · Cited by 147
Toiyama, Y., Miki, C., Inoue, Y., Tanaka, K., Mohri, Y., & Kusunoki, M. (2010) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2010.175 · Cited by 144
Prognostic Factors in Advanced Gastrointestinal Cancer Patients With Weight Loss
O'Gorman, P., McMillan, D. C., & McArdle, C. S. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc3701_4 · Cited by 135
Dutta, S., Crumley, A. B. C., Fullarton, G. M., Horgan, P. G., & McMillan, D. C. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1130-7 · Cited by 132
Torre, M. L., Nigri, G. R., Cavallini, M., Mercantini, P., Ziparo, V., & Ramacciato, G. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2348-9 · Cited by 126
Ravishankaran, P., & Karunanithi, R. (2011) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-9-18 · Cited by 125
Predictors of survival in stage IV metastatic colorectal cancer.
Zacharakis, M., Xynos, I. D., Lazaris, A. C., Smaro, T., Kosmas, C., Dokou, A., Felekouras, E. S., Antoniou, E., Polyzos, A., Sarantonis, J., et al. (2010) · PubMed · Cited by 123
Ikeda, M., Natsugoe, S., Ueno, S., Baba, M., & Aikou, T. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000080822.22415.cb · Cited by 122
Christakis, N. (2000) · Western Journal of Medicine · doi:10.1136/ewjm.172.5.310 · Cited by 122
Vashist, Y. K., Loos, J., Dedow, J., Tachezy, M., Uzunoglu, G., Kutup, A., Yekebas, E. F., & Izbicki, J. R. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1383-7 · Cited by 121
Miki, C., Konishi, N., Ojima, E., Hatada, T., Inoue, Y., & Kusunoki, M. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000034556.48527.6e · Cited by 118
Serum interleukin-6 and -10 levels in patients with gastric cancer
Ikeguchi, M., Hatada, T., Yamamoto, M., Miyake, T., Matsunaga, T., Fukumoto, Y., Yamada, Y., Fukuda, K., Saito, H., & Tatebe, S. (2009) · Gastric Cancer · doi:10.1007/s10120-009-0509-8 · Cited by 116
Kwon, K. A., Kim, S. H., Oh, S. Y., Lee, S., Han, J., Kim, K. H., Goh, R.-Y., Choi, H. J., Park, K., Roh, M. S., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-203 · Cited by 116
Impact of C-Reactive Protein Kinetics on Survival of Patients with Metastatic Renal Cell Carcinoma
Saito, K., Tatokoro, M., Fujii, Y., et al. (2008) · European Urology · doi:10.1016/j.eururo.2008.10.012 · Cited by 115
Ishizuka, M., Nagata, H., Takagi, K., & Kubota, K. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b16e24 · Cited by 115
The RANX05 Colorectal Cancer Study Group, Nielsen, H. J., Christensen, I. J., Sørensen, S., Moesgaard, F., & Brünner, N. (2000) · Annals of Surgical Oncology · doi:10.1007/bf02725342 · Cited by 115
Elahi, M. M., McMillan, D. C., McArdle, C. S., Angerson, W. J., & Sattar, N. A. (2004) · Nutrition and Cancer · doi:10.1207/s15327914nc4802_6 · Cited by 113
C-Reactive Protein and All-Cause Mortality in a Large Hospital-Based Cohort
Marsik, C. L., Kazemi-Shirazi, L., Schickbauer, T., Winkler, S., Joukhadar, C., Wagner, O. F., & Endler, G. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.091959 · Cited by 112
Deans, D. A. C., Wigmore, S. J., Gilmour, H. M., Paterson‐Brown, S., Ross, J. A., & Fearon, K. C. H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603446 · Cited by 110
Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer
Jones, J. M., McGonigle, N. C., McAnespie, M., Cran, G. W., & Graham, A. N. J. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.03.012 · Cited by 108
Beer, T. M., Lalani, A. S., Lee, S. J., Mori, M., Eilers, K. M., Curd, J. G., Henner, W. D., Ryan, C. W., Venner, P. M., Ruether, J. D., et al. (2008) · Cancer · doi:10.1002/cncr.23461 · Cited by 107
Müller, M. W., Frieß, H., Köninger, J., Martin, D. J., Wente, M. N., Hinz, U., Ceyhan, G. O., Blaha, P., Kleeff, J. H., & Büchler, M. W. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.02.026 · Cited by 106
Emery, P., Gabay, C., Kraan, M. C., & Gómez-Reino, J. J. (2007) · Rheumatology International · doi:10.1007/s00296-007-0357-y · Cited by 105
Systemic Inflammatory Response Predicts Prognosis in Patients with Advanced-Stage Colorectal Cancer
Sharma, R., Zucknick, M., London, R. M., Kacevska, M., Liddle, C., & Clarke, S. J. (2008) · Clinical Colorectal Cancer · doi:10.3816/ccc.2008.n.044 · Cited by 103
1120: Evaluation of an Inflammation Based Prognostic Score in Patients with Metastatic Renal Cancer
Ramsey, S., Lamb, G. W. A., Graham, J. D., & Aitchison, M. (2007) · The Journal of Urology · doi:10.1016/s0022-5347(18)31334-x · Cited by 100
Tartour, É., Blay, J., Dorval, T., Escudier, B. J., Mosseri, V., Douillard, J., Deneux, L., Gorin, I., Négrier, S., Mathiot, C., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1697 · Cited by 98
Can clinically localized prostate cancer be managed conservatively?
Klotz, L. H. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0292 · Cited by 98
Wang, C., Hsieh, M.-J., Chiu, Y., Li, S.-H., Huang, H., Fang, F., & Huang, Y.-J. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.01.002 · Cited by 95
Leung, E. Y. L., Scott, H. R., & McMillan, D. C. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318244ffe1 · Cited by 95
C-reactive protein is a prognostic parameter in patients with cervical cancer
Polterauer, S., Grimm, C., Tempfer, C., Sliutz, G., SPEISER, P., Reinthaller, A., & Hefler, L. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.06.001 · Cited by 95
Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer
Ishizuka, M., Nagata, H., Takagi, K., Iwasaki, Y., & Kubota, K. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23163 · Cited by 93
Kobayashi, T., Teruya, M., Kishiki, T., Endo, D., Takenaka, Y., Tanaka, H., Miki, K., Kobayashi, K., & Morita, K. (2008) · Surgery · doi:10.1016/j.surg.2008.08.015 · Cited by 93
Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma
Hotta, K., Sho, M., Fujimoto, K., Shimada, K., Yamato, I., Anai, S., Konishi, N., Hirao, Y., Nonomura, K., & Nakajima, Y. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.368 · Cited by 92
High-Sensitivity C-Reactive Protein Levels and Cancer Mortality
Ko, Y.-J., Kwon, Y.-M., Kim, K. H., Choi, H.-C., Chun, S., Yoon, H., Goh, E., Cho, B., & Park, M. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0611 · Cited by 90
BARBER, M. D., Fearon, K. C. H., & Ross, J. A. (1999) · Clinical Science · doi:10.1042/cs0960083 · Cited by 89
Groblewska, M., Mroczko, B., Wereszczyńska-Siemiątkowska, U., Kędra, B., Łukaszewicz‐Zając, M., Baniukiewicz, A., & Szmitkowski, M. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.278 · Cited by 88
Hwang, J., Kim, H.-N., Kim, D.-E., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-489 · Cited by 88
Dutta, S., Crumley, A. B. C., Fullarton, G. M., Horgan, P. G., & McMillan, D. C. (2012) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2011.10.015 · Cited by 88
Ramsey, S., Lamb, G. W. A., Aitchison, M., & McMillan, D. C. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07363.x · Cited by 84
Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer
Wigmore, S. J., MacMahon, A. J., Sturgeon, C., & Fearon, K. C. H. (2001) · British journal of surgery · doi:10.1046/j.1365-2168.2001.01669.x · Cited by 84
Gioulbasanis, I., Georgoulias, P., Vlachostergios, P. J., Baracos, V. E., Ghosh, S., Giannousi, Z., Papandreou, C. N., Mavroudis, D., & Georgoulias, V. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.05.009 · Cited by 82
Jeong, J.-H., Lim, S. M., Yun, J. Y., Rhee, G. W., Lim, J. Y., Choi, Y., & Kim, Y. R. (2012) · Oncology · doi:10.1159/000342376 · Cited by 82
Walsh, D., Mahmoud, F. A., & Barna, B. P. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-002-0390-z · Cited by 81
Self-citationShafique, K., Proctor, M. J., McMillan, D. C., Qureshi, K. N., Leung, H. Y., & Morrison, D. S. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.60 · Cited by 81
Identification of Clinically Useful Cancer Prognostic Factors: What Are We Missing?
McShane, L. M., Altman, D. G., & Sauerbrei, W. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji193 · Cited by 79
Volkova, E., Willis, J. A., Wells, J. E., Robinson, B. A., Dachs, G. U., & Currie, M. J. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606005 · Cited by 78
Serum Levels of Leptin and Proinflammatory Cytokines in Advanced-Stage Non-Small Cell Lung Cancer
Taş, F., Duranyıldız, D., Argon, A., Oğuz, H., Çamlıca, H., Yasasever, V., & Topuz, E. (2005) · Medical Oncology · doi:10.1385/mo:22:4:353 · Cited by 78
Lamb, G. W. A., McMillan, D. C., Ramsey, S., & Aitchison, M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603034 · Cited by 78
Clinical predictors of survival in advanced cancer.
Glare, P. A. (2005) · PubMed · Cited by 75
Johnson, T., Abbasi, A., Owen‐Smith, A. A., Young, A. N., Ogan, K., Pattaras, J. G., Nieh, P. T., Marshall, F. F., & Master, V. A. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.10.014 · Cited by 74
Clinical significance of pretreatment serum C‐reactive protein level in soft tissue sarcoma
Nakamura, T., Matsumine, A., Matsubara, T., Asanuma, K., Uchida, A., & Sudo, A. (2011) · Cancer · doi:10.1002/cncr.26353 · Cited by 73
Is High-Sensitivity C-Reactive Protein an Effective Screening Test for Cardiovascular Risk?
Kushner, I., & Sehgal, A. R. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.8.867 · Cited by 73
Jagdev, S., Gregory, W. M., Vasudev, N. S., Harnden, P., Sim, S., Thompson, D., Cartledge, J. J., Selby, P. J., & Banks, R. E. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605973 · Cited by 73
Chung, Y., & Chang, Y.-F. (2003) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200304000-00006 · Cited by 72
Crozier, J. E. M., Leitch, E. F., McKee, R. F., Anderson, J. H., Horgan, P. G., & McMillan, D. C. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.12.052 · Cited by 71
Richards, C., Leitch, E. F., Horgan, P. G., Anderson, J. H., McKee, R. F., & McMillan, D. C. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605919 · Cited by 70
Using C-reactive protein to assess cardiovascular disease risk.
Shishehbor, M. H., Bhatt, D. L., & Topol, E. J. (2003) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.70.7.634 · Cited by 70
Łukaszewicz‐Zając, M., Mroczko, B., Gryko, M., Kędra, B., & Szmitkowski, M. (2010) · Clinical and Experimental Medicine · doi:10.1007/s10238-010-0114-5 · Cited by 69
Lamb, G. W. A., Aitchison, M., Ramsey, S., Housley, S. L., & McMillan, D. C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.556 · Cited by 69
Kelly, L., White, S. J., & Stone, P. C. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm138 · Cited by 68
Gioulbasanis, I., Pallis, A. G., Vlachostergios, P. J., Xyrafas, A., Giannousi, Z., Perdikouri, I.-E., Makridou, M., Kakalou, D., & Georgoulias, V. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.04.008 · Cited by 63
Sim, S., Messenger, M. P., Gregory, W. M., Wind, T. C., Vasudev, N. S., Cartledge, J. J., Thompson, D., Selby, P. J., & Banks, R. E. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.360 · Cited by 63
Skipworth, R. J. E., Moses, A. G. W., Sangster, K., Sturgeon, C. M., Voss, A. C., Fallon, M., Anderson, R. A., Ross, J. A., & Fearon, K. C. H. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0832-y · Cited by 61
Crozier, J. E. M., McKee, R. F., McArdle, C. S., Angerson, W. J., Anderson, J. H., Horgan, P. G., & McMillan, D. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603185 · Cited by 61
Levels of some Acute-Phase Proteins in the Serum of Patients with Cancer during Radiotherapy
Koç, M., Tayşi, S., Sezen, O., & Bakan, N. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.1494 · Cited by 60
Bromwich, E., McMillan, D. C., Lamb, G. W. A., Vasey, P. A., & Aitchison, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602152 · Cited by 58
Fabbro, E. D., Hui, D., Nooruddin, Z. I., Dalal, S., Dev, R., Freer, G., Roberts, L., Palmer, J. L., & Bruera, E. D. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.09.021 · Cited by 55
Miyata, H., Yamasaki, M., Kurokawa, Y., Takiguchi, S., Nakajima, K., Fujiwara, Y., Mori, M., & Doki, Y. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.308 · Cited by 54
Johnson, T., Abbasi, A., Owen‐Smith, A. A., Young, A. N., Kucuk, O., Harris, W. B., Osunkoya, A. O., Ogan, K., Pattaras, J. G., Nieh, P. T., et al. (2010) · Urology · doi:10.1016/j.urology.2010.01.052 · Cited by 54
Is C-Reactive Protein a Prognostic Factor of Colorectal Cancer?
Shiu, Y.-C., Lin, J.-K., Huang, C., Jiang, J., Wang, L.-W., Huang, H., & Yang, S.-H. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-9133-z · Cited by 53
Nozoe, T., Mori, E., Takahashi, I., & Ezaki, T. (2008) · Surgery Today · doi:10.1007/s00595-007-3680-8 · Cited by 53
Nozoe, T., Iguchi, T., Adachi, E., Matsukuma, A., & Ezaki, T. (2011) · Surgery Today · doi:10.1007/s00595-009-4297-x · Cited by 52
Lamb, G. W. A., McArdle, P., Ramsey, S., McNichol, A., Edwards, J., Aitchison, M., & McMillan, D. C. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07666.x · Cited by 52
Haas, M., Laubender, R. P., Stieber, P., Holdenrieder, S., Bruns, C. J., Wilkowski, R., Mansmann, U., Heinemann, V., & Boeck, S. H. (2010) · Tumor Biology · doi:10.1007/s13277-010-0044-6 · Cited by 52
Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer
Wood, S. L., Rogers, M., Cairns, D. A., Paul, A., Thompson, D., Vasudev, N. S., Selby, P. J., & Banks, R. E. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605720 · Cited by 51
Fujiwara, H., Suchi, K., Okamura, S., et al. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21751 · Cited by 49
Peccatori, J., Barkholt, L., Demirer, T., Sormani, M. P., Bruzzi, P., Ciceri, F., Zambelli, A., Prada, G. A. D., Pedrazzoli, P., Siena, S., et al. (2005) · Cancer · doi:10.1002/cncr.21477 · Cited by 48
Tanaka, T., Ikeda, M., Okusaka, T., Ueno, H., Morizane, C., Hagihara, A., Iwasa, S., & Kojima, Y. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn098 · Cited by 48
Roxburgh, C. S. D., Platt, J. J., Leitch, E. F., Kinsella, J., Horgan, P. G., & McMillan, D. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-1410-8 · Cited by 47
Ishizuka, M., Nagata, H., Takagi, K., Iwasaki, Y., & Kubota, K. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2384-5 · Cited by 46
Ito, M., Saito, K., Yasuda, Y., Sukegawa, G., Kubo, Y., Numao, N., Kitsukawa, S., Urakami, S., Yuasa, T., Yamamoto, S., et al. (2011) · Urology · doi:10.1016/j.urology.2011.07.1416 · Cited by 46
C-reactive protein levels: a prognostic marker for patients with head and neck cancer?
Kruse, A. L., Lübbers, H., & Grätz, K. W. (2010) · Head & Neck Oncology · doi:10.1186/1758-3284-2-21 · Cited by 46
Guida, M., CASAMASSIMA, A., Monticelli, G., Quaranta, M., & Colucci, G. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-51 · Cited by 43
Kobayashi, T., Teruya, M., Kishiki, T., Endo, D., Takenaka, Y., Miki, K., Kobayashi, K., & Morita, K. (2010) · Digestive Surgery · doi:10.1159/000280021 · Cited by 42
Significance of inflammatory cytokines in the progression of colorectal cancer.
Chung, Y., & Chang, Y.-F. (2004) · PubMed · Cited by 41
Introduction: Tumor markers as clinical cancer tests—are we there yet?
Schilsky, R. L., & Taube, S. E. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.32890 · Cited by 41
Chua, W. M., Clarke, S. J., & Charles, K. A. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-011-1289-3 · Cited by 39
Evaluation of predictive markers for patients with advanced colorectal cancer
Byström, P., Berglund, Å., Nygren, P., Wernroth, L., Johansson, B., Larsson, A. O., & Glimelius, B. L. G. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.705020 · Cited by 39
C-reactive protein is a potential prognostic factor for metastatic gastric cancer.
Shimura, T., Kitagawa, M., Yamada, T., et al. (2012) · PubMed · Cited by 38
Prognostic value of circulating cytokines for stage III colon cancer
Lee, W. S., Baek, J., You, D. H., & Nam, M. J. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.08.051 · Cited by 35
Presence of tumoural C-reactive protein correlates with progressive prostate cancer
Elsberger, B., Lankston, L., McMillan, D. C., Underwood, M. A., & Edwards, J. (2011) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2011.5 · Cited by 32
An approach to estimating prognosis using fractional polynomials in metastatic renal carcinoma
Royston, P. J., Reitz, M., & Atzpodien, J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603192 · Cited by 30
Fuzzy Logic-Based Prognostic Score for Outcome Prediction in Esophageal Cancer
Wang, C., Lee, T.-F., Fang, C., & Chou, J. (2012) · IEEE Transactions on Information Technology in Biomedicine · doi:10.1109/titb.2012.2211374 · Cited by 30
Kobayashi, T., Teruya, M., Kishiki, T., Kaneko, S., Endo, D., Takenaka, Y., Miki, K., Kobayashi, K., & Morita, K. (2010) · Digestive Surgery · doi:10.1159/000276910 · Cited by 30
Prognostic Significance of Body Mass Index in Asian Patients With Localized Renal Cell Carcinoma
Komura, K., Inamoto, T., Black, P. C., Koyama, K., Katsuoka, Y., Watsuji, T., & Azuma, H. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.594207 · Cited by 30
Developing a Rational Tumor Vaccine Therapy for Renal Cell Carcinoma: Immune Yin and Yang
Ernstoff, M. S., Crocenzi, T. S., Seigne, J. D., Crosby, N. A., Cole, B. F., Fisher, J. L., Uhlenhake, J. C., Mellinger, D., Foster, C., Farnham, C. J., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2064 · Cited by 29
Kawashima, A., Tsujimura, A., Takayama, H., et al. (2012) · International Journal of Urology · doi:10.1111/j.1442-2042.2012.03115.x · Cited by 29
Falkensammer, C. E., Thurnher, M., Leonhartsberger, N., & Ramoner, R. E. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09817.x · Cited by 28
Association of C-reactive Protein Gene Polymorphisms and Colorectal Cancer
Yang, S.-H., Huang, C., Chang, S., & Lin, J.-K. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1575-9 · Cited by 25
Iwasa, S., Nakajima, T. E., Nakamura, K., et al. (2010) · International Journal of Clinical Oncology · doi:10.1007/s10147-010-0135-9 · Cited by 23
de Jong, K. P., Hoedemakers, R. M. J., Fidler, V., Bijzet, J., Limburg, P. C., Peeters, P. M. J. G., de Vries, E. G. E., & Slooff, M. J. H. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410009609 · Cited by 23
Masago, K., Fujita, S., Togashi, Y., Kim, Y. H., Hatachi, Y., Fukuhara, A., Nagai, H., Irisa, K., Sakamori, Y., Okuda, C., et al. (2010) · Oncology · doi:10.1159/000323486 · Cited by 22
McMillan, D. C., Canna, K., & McArdle, C. S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601156 · Cited by 21
van de Poll, M. C. G., Klaver, Y. L. B., Lemmens, V. E. P. P., Leenders, B. J. M., Nienhuijs, S. W., & de Hingh, I. H. J. T. (2011) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1187-7 · Cited by 17
Grimm, M. R., & Lazariotou, M. (2011) · Medical Oncology · doi:10.1007/s12032-011-0045-3 · Cited by 16
Kunisaki, C., Takahashi, M., Ono, H. A., Oshima, T., Takagawa, R., Kimura, J., Kosaka, T., Makino, H., Akiyama, H., & Endo, I. (2012) · Oncology · doi:10.1159/000341346 · Cited by 15
Hemelrijck, M. V., Eichholzer, M., Faeh, D., & Rohrmann, S. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-895 · Cited by 14
Melichar, B., Krčmová, L. K., Kalábová, H., Holečková, P., Kašparová, M., Plíšek, J., Hyšpler, R., Študentová, H., & Solichová, D. (2010) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.56.222 · Cited by 13
Ishizuka, M., Nagata, H., Takagi, K., et al. (2012) · PubMed · Cited by 12
Morizane, S., Iwamoto, H., Yao, A., Isoyama, T., Sejima, T., & Takenaka, A. (2012) · Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication · doi:10.5173/ceju.2012.02.art1 · Cited by 8
Cited by
Inter-tissue communication in cancer cachexia
Argilés, J. M., Stemmler, B., López-Soriano, F. J., & Busquets, S. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0123-0 · Cited by 305
C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights
Hart, P. C., Rajab, I. M., Alebraheem, M., & Potempa, L. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.595835 · Cited by 275
Learning from clinical trials of neoadjuvant checkpoint blockade
Versluis, J. M., Long, G. V., & Blank, C. U. (2020) · Nature Medicine · doi:10.1038/s41591-020-0829-0 · Cited by 234
Fankhauser, C. D., Sander, S., Roth, L., Gross, O., Eberli, D., Sulser, T., Seifert, B., Beyer, J., & Hermanns, T. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.467 · Cited by 80
Nutrition Care Process Model Approach to Surgical Prehabilitation in Oncology
Gillis, C., Hasil, L., Kasvis, P., Bibby, N., Davies, S. J., Prado, C. M., West, M. A., & Shaw, C. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.644706 · Cited by 46
Metadata
- Authors
- Shrotriya, S., Walsh, D., Bennani-Baiti, N., Thomas, S., & Lorton, C.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-12-30
- Volume
- 10
- Issue
- 12
- Pages
- e0143080
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2200286273
- Cited by
- 274
- References
- 160
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.